Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Cariprazine in Schizophrenia
This study has been completed.
Study NCT01104779   Information provided by Forest Laboratories

First Received on April 14, 2010.   Last Updated on December 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Cariprazine
Placebo
Additional drug interventions recognized in this trial
Antipsychotic Agents
Central Nervous System Agents
More general drug interventions related to this trial
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Forest Laboratories
Gedeon Richter Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services